RESEARCHDIAGNOSTICSTRANSLATIONOUTREACH
 
Project Detail
mTOR expression in breast carcinomas and the ability of everolimus (RAD 001) to modulate its expression
 
Team
Fernando Schmitt (PI), André Albergaria, Joana Paredes, José Costa, Sílvia Carvalho
 
Sponsor
Novartis Farma
 
Dates and Lifetime
From: 2009-11-02 To: 2012-11-02
Duration: 36 months
 
Reference
  
 
@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto
A
A
A

Send Email
From
To
Subject